Nitrophenylpiperazine derivatives as novel tyrosinase inhibitors: design, synthesis, and in silico evaluations.

Autor: Asadi M; Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran., Fayazi F; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Iraji A; Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran., Sabourian R; Drug and Food Control Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Azizian H; Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran., Hajimahmoodi M; Drug and Food Control Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Larijani B; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran., Mahdavi M; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran. mahdavi_chem@yahoo.com., Amanlou M; Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. amanlou@tums.ac.ir.; Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran. amanlou@tums.ac.ir.

Publikováno v: BMC chemistry [BMC Chem] 2024 Apr 05; Vol. 18 (1), pp. 67. Date of Electronic Publication: 2024 Apr 05.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Thioquinoline derivatives conjugated to thiosemicarbazide as potent tyrosinase inhibitors with anti-melanogenesis properties.

Autor: Noori M; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran., Sabourian R; Drug and Food Control Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Tasharoie A; Drug and Food Control Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Safavi M; Department of Biotechnology, Iranian Research Organization for Science and Technology (IROST), Tehran, Iran., Iraji A; Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran., Khalili Ghomi M; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran., Dastyafteh N; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran., Irajie C; Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran., Zarenezhad E; Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Mostafavi Pour SM; Liosa Pharmed Parseh Company, Shiraz, Iran., Rasekh F; Department of Biology, Payame Noor University(PNU), Tehran, Iran., Larijani B; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran., Amini M; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Hajimahmoodi M; Drug and Food Control Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. hajimah@tums.ac.ir.; Halal Research Center of IRI, Food and Drug Administration, Ministry of Health and Medical Education, Tehran, Iran. hajimah@tums.ac.ir., Mahdavi M; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. momahdavi@sina.tums.ac.ir.

Publikováno v: Scientific reports [Sci Rep] 2023 Feb 13; Vol. 13 (1), pp. 2578. Date of Electronic Publication: 2023 Feb 13.

In vitro cell-based models of drug-induced hepatotoxicity screening: progress and limitation.

Autor: Mirahmad M; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Sabourian R; Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran., Mahdavi M; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Larijani B; Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Safavi M; Department of Biotechnology, Iranian Research Organization for Science and Technology, Tehran, Iran.

Publikováno v: Drug metabolism reviews [Drug Metab Rev] 2022 May; Vol. 54 (2), pp. 161-193. Date of Electronic Publication: 2022 Apr 22.

Therapeutic applications of biosimilar monoclonal antibodies: Systematic review of the efficacy, safety, and immunogenicity in autoimmune disorders.

Autor: Mirjalili SZ; Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Sabourian R; Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran., Sadeghalvad M; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran., Rezaei N; Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: rezaei_nima@tums.ac.ir.

Publikováno v: International immunopharmacology [Int Immunopharmacol] 2021 Dec; Vol. 101 (Pt B), pp. 108305. Date of Electronic Publication: 2021 Nov 03.